FORCED VITAL CAPACITY DECREASED

#	Drug	Count
0	OMALIZUMAB	156
1	ALBUTEROL SULFATE	143
2	TIOTROPIUM BROMIDE	124
3	PREDNISONE	116
4	BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE	96
5	MONTELUKAST SODIUM	86
6	PIRFENIDONE	78
7	AMLODIPINE	63
8	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	63
9	PANTOPRAZOLE	50

#	Drug	Count	Frequency
0	SODIUM FUSIDATE	5	0.0108
1	GALANTAMINE HYDROBROMIDE	6	0.0038
2	CICLESONIDE	31	0.0034
3	OMALIZUMAB	156	0.0032
4	INFLUENZA A VIRUS, INFLUENZA B VIRUS, HISTAMINUM HYDROCHLORICUM, ACONITUM NAP., ARALIA QUINQUEFOLIA, ARSENICUM ALB., BAPTISIA, BRYONIA, CINCHONA, EUPATORIUM PERF., GELSEMIUM, IPECAC., KALI CARB., NUX VOM., PHOSPHORUS, RHUS TOXICODENDRON, ECHINACEA	1	0.0028
5	PIRFENIDONE	78	0.0027
6	NINTEDANIB	31	0.0022
7	GLYCOPYRRONIUM	2	0.0019
8	THEOPHYLLINE	17	0.0018
9	MEPOLIZUMAB	40	0.0018

#	Drug class	Count
0	Corticosteroid [EPC]	173
1	Anti-IgE [EPC]	156
2	Pyridone [EPC]	78
3	Dihydropyridine Calcium Channel Blocker [EPC]	64
4	Calcium Channel Blocker [EPC]	63
5	Proton Pump Inhibitor [EPC]	60
6	Nonsteroidal Anti-inflammatory Drug [EPC]	58
7	Platelet Aggregation Inhibitor [EPC]	51
8	HMG-CoA Reductase Inhibitor [EPC]	42
9	Interleukin-5 Antagonist [EPC]	40

#	Drug class	Count	Frequency
0	Anti-IgE [EPC]	156	0.0032
1	Pyridone [EPC]	78	0.0027
2	Interleukin-5 Antagonist [EPC]	40	0.0018
3	Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]	2	0.0012
4	Antisense Oligonucleotide [EPC]	5	0.0009
5	beta3-Adrenergic Agonist [EPC]	19	0.0008
6	Prostaglandin E1 Analog [EPC]	10	0.0007
7	Thiazide-like Diuretic [EPC]	19	0.0006
8	P2Y12 Platelet Inhibitor [EPC]	13	0.0006
9	Stimulant Laxative [EPC]	5	0.0005